Clinical trial

BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis

NCT02430532

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-05-01

PhasePHASE3

Study timeline

Study start (unknown)2015-05-01Date precision: month

Registry last updated2017-04-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Secondary Progressiveunresolved

Interventions

dimethyl fumarateDRUG · verified · RxNorm: dimethyl fumarate

PlaceboOTHER

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

San FranciscoCalifornia, United States1 TampaFlorida, United States1 CharlotteNorth Carolina, United States1 BrusselsBelgium1 Long BeachCalifornia, United States1 KrakowPoland1 PoznanPoland1 LodzPoland1 GdanskPoland1 BrnoCzechia1 KatowicePoland1 Hradec KrálovéCzechia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02430532 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.